Target intelligence / Profile preview

Keratin and intercellular lipid in stratum corneum

Molecular classification
Other (keratin: fibrous structural protein, intermediate filament), Other (intercellular lipid: lipid matrix, mixture of ceramides, cholesterol, free fatty acids)
01

Overview

Keratin and intercellular lipid in the stratum corneum are not individual molecular drug targets but essential structural components of the outermost skin layer, forming the major **barrier system of skin**. **Keratin** is a structural protein in corneocytes (flattened dead skin cells), providing mechanical strength and water-binding capacity[3][4]. **Intercellular lipids** (mainly ceramides, cholesterol, and free fatty acids) fill the spaces between corneocytes as a “mortar” in a brick-and-mortar model, preventing water loss and entry of pathogens or chemicals[4][3]. The integrity and organization of both keratin filaments and lipid layers are crucial for maintaining barrier properties, hydration, and defence against environmental hazards. Disruption of this balance is associated with various skin disorders (e.g., eczema, psoriasis), and topical therapies often aim to restore or protect these structural elements[4][3]. **Note**: "Keratin and intercellular lipid in stratum corneum" refers to a composite matrix, not a discrete receptor, enzyme, or protein target. It may be too general/incorrect as a "therapeutic target" per the usual pharmacological definition.

Other names
Stratum corneum keratin and lipidSC keratin and lipidCorneocyte keratin and lipid matrix
02

Mechanism of action

Restoration of lipid matrix (replacement creams); Occlusion and hydration (emollients, moisturizers); Disruption of protein/lipid matrix (keratolytics, surfactants); Modulation of keratinocyte turnover (retinoids)

03

Biological functions

Skin barrier functionPrevention of water lossMechanical protectionDefense against pathogens and toxinsRegulation of hydration
04

Disease associations

Inflammation (eczema, dermatitis)Infection (compromised barrier)Other (ichthyosis, xerosis, psoriasis, atopic dermatitis)
05

Safety considerations

Barrier disruption leading to increased sensitivity or susceptibility to infection (from surfactants, excessive use of keratolytics)Allergic reactions to topical agentsIrritation and dryness
06

Interacting drugs

Moisturizers (contain ceramides, cholesterol, fatty acids)

6 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Stratum corneum hydration levelsCorneocyte protein/keratin contentLipid profile (ceramide content)

Beyond the preview

Go deeper on Keratin and intercellular lipid in stratum corneum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin and intercellular lipid in stratum corneum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call